Professional Documents
Culture Documents
levels are very low, w ith severe acidosis and base deficit. In this situation the next
immediate treatment is with sodium bicarbonate, the 8.4% concentration should be given via
central line over 3040 min. It is almost as important to begin treatment for inhibition of
alcohol dehydrogenase as soon as possible. Fomepizole or alcohol may be given as inhibitors of
alcohol dehydrogenase. Fomepizole has the advantage of not decreasing conscious level. It is
likely that haemodialysis will be required; in patients requiring haemodialysis either the
alcohol infusion rate or dose interval between doses of fomepizole requires alteration. As little
as 30 ml of ethylene glycol may be fatal in adults, plasma levels of >500 mg/l indicate a severe
overdose, and degree of acidosis is predictive of outcome.
Amphetamine overdose is associated with mydriasis, hypertension, tachycardia, skin pallor,
hyperexcitability and, in the initial stages, agitation and increased talkativeness. Poor
prognostic features associated with amphetamine overdose include hyperpyrexia,
rhabdomyolysis, acute renal failure and acute liver failure. Complications include intracerebral
haemorrhage, which may occur after a single amphetamine dose. Any patients who show focal
signs or decreased conscious level should raise suspicion of the possibility of intracerebral
haemorrhage. Hypertension should be controlled with beta blockade, and agitated patients may
be sedated with benzodiazepines.
Ecstasy is an amfetamine derivative (methylenedioxymethamfetamine, MDMA) and its effect is
to cause stimulation of the sympathetic nervous system. The effects of ecstasy usually occur
within 1 hour and typically last for 46 hours, although in large ingestions they can last for up
to 48 hours. Unwanted effects include cardiac arrhythmias (the principal cause of MDMA-
associated deaths), hyponatraemia, hypertension and hyperthermia. Hyponatraemia can occur
either because of an excessive fluid intake or because of SIADHS (syndrome of inappropriate
antidiuretic hormone secretion). Treatment of hyperthermia includes giving cold intravenous
fluids if the core temperature is over 39 C: if this is ineffective, it should be followed by iv
dantrolene and/or paralysis and ventilation.
Ecstasy (3,4-methylenedioxymethamfetamine, MDMA) stimulates the central nervous system.
Poisoning with this drug is usually the result of its recreational use rather than a single massive
dose.
Gastric lavage should be considered if a substantial overdose has been ingested in the
preceding 1 hour. The dehydration should be corrected. All patients should be transferred to
A&E and observed and monitored for at least 6 hours for the electrocardiogram (ECG) and
electrolyte balance. Diazepam should be given if the patient convulses. Cooling measures (fan,
sponging, ice packs, cool iv fluids) should be instigated if the rectal temperature rises above 39
C. If this is unsuccessful, the patient will need to be paralysed and ventilated.
b-Adrenoceptor blocking drugs will antagonise the peripheral sympathomimetic actions of
amfetamines. These drugs cause increased alertness and self-confidence, euphoria, extrovert
behaviour, increased talkativeness with rapid speech, lack of desire to eat or sleep, tremor,
dilated pupils, tachycardia and hypertension.
Generic medicines are produced by companies who are subject to the same tight controls as
those who make branded products. In fact, the same company often makes branded and
generic medicines. Generic medicines contain the same active ingredients, are of the same
dosage form and are identical in strength to the original medicine. They have to be
therapeutically equivalent to their branded product, which means that the maximum
concentration (C
max
), the area under the curve (AUC) and the time of maximum concentration
(t
max
) must be comparable to the already registered drug. This means that they work in the
same way in the body and are associated with the same risks and benefits of the original
medicine. Different generic forms of the same medicine will not differ in their safety and
clinical actions from each other or their branded equivalent.
A pharmaceutical company wants to bring generic ranitidine to the market after the patent has
expired.
What kind of study is needed to obtain approval to market the drug?
Phase-I bioequivalence study
Glucocorticoids include cortisone and hydrocortisone, which have a low mineralocorticoid
activity, along with prednisolone, betamethasone and dexamethasone. For replacement
therapy, hydrocortisone in combination with fludrocortisone is used; this latter drug has little
anti-inflammatory activity.
The strength of the anti-inflammatory effects of 5 mg prednisolone =
Betamethasone 750 g
Cortisone acetate 25 mg
Deflazacort 6 mg
Dexamethasone 750 g
Hydrocortisone 20 mg
Methylprednisolone 4 mg
Antacids tend to alkalinise the urine, leading to increased urinary aspirin clearance, whereas
metoclopramide enhances its absorption. Aspirin diminishes the actions of uricosuric agents
such as probenicid and sulfinpyrazone.
The following are first-line treatments for the other conditions:
Rheumatic fever: phenyloxymethylpenicillin
Meningococcal meningitis: rifampicin (ciprofloxacin for pregnant women and young
children)
Haemophilus influenzae type B: rifampicin.
NSAIDs are disease-modifying drugs. They decrease the antihypertensive effect of
angiotensin-converting enzyme inhibitors and therefore increase the risk of renal failure and
hyperkalaemia. They antagonise the effects of -blockers and inhibit cyclo-oxygenase. Many
of the renal side-effects arise from the prostaglandin-inhibiting properties of NSAIDs. In the
kidney NSAIDs cause vasoconstriction, a decreased glomerular filtration rate and sodium and
water retention, oppose the action of loop diuretics, augment the action of antidiuretic
hormone (water retention) and cause hypernatraemia, hyperaldosteronism and hyperkalaemia.
Side-effects of using NSAIDs include interstitial nephritis and nephrotic proteinuria but not
nephritic syndrome. Eosinophilic infiltrates are often found on biopsy. Other complications
include nausea and rashes.
This drug is a class 3 antiarrhythmic drug. It is a vasodilator of both the peripheral and the central
circulation, and is a negative chronotrope. It has a half-life of 78 weeks and needs a loading dose.
It acts to prolong the action potential in the refractory period. It also prolongs the QT and QRS
complexes and is a sodium channel blocker. It directly decreases the automaticity of the sinus and
the autonomic nervous system, and has a a- and -blocking properties.
What is this drug?
Amiodarone has the above properties, successfully suppresses an arrhythmia and does not
cause mortality. It was used in the Basal Antiarrhythmic Study of Infarction Survey (BASIS)
and found to be of benefit. It decreased all arrhythmias compared with a placebo and other
antiarrhythmic medication. The study did, however, conclude that -blockers were still the
best medication for a post-myocardial infarct.
Amiodarone potentiates digoxin, as it competes with it at digoxin-binding sites, warfarin,
other antiarrhythmics and iodine content. It may therefore potentiate hyperthyroidism and
may subsequently inhibit the conversion of thyroxine to active T
3
and cause hypothyroidism.
Other side-effects include reversible corneal microdeposits, optic neuritis, slate-grey skin
syndrome, photosensitivity, pulmonary fibrosis, alveolitis, hepatitis, peripheral neuropathy,
myopathy, hyperthyroidism, hypothyroidism (10%), heart block, dermatitis, tremor,
gastrointestinal disturbance, lung amiodarone pulmonary disease, bradycardia, raised
intracranial pressure, vasculitis and thrombocytopenia. It may be well tolerated in low doses
and is effective in the prevention and cardioversion of atrial flutter and fibrillation.
This antiepileptic medication is used to enhance the action of -aminobutyric acid,
which is a major inhibitory neurotransmitter. It is used in absence attacks, temporal
lobe epilepsy and myoclonic-type epilepsy. It inhibits liver enzymes and may enhance
the function of other antiepileptic agents such as phenytoin, causing toxicity.
What is this medication?
Sodium valproate has many dose-related side effects, including thrombocytopenia, tremor,
appetite stimulation, alopecia, ataxia, fatal hepatitis, gastric irritation, pancreatitis, menstrual
irregularities, encephalopathy, hyperammonaemia (20%) and hepatotoxicity (1 in 20,000).
Plasma levels are required to determine the efficacy of the clinical response. Sodium
valproate is not used for infantile spasms (nitrazepam, adrenocorticotrophic hormone or
prednisolone are used instead) or status epilepticus (lorazepam and phenytoin).
A teenager presents unconscious in the emergency department. Her parents give a
history that she had been drinking the night before. During the night, she complained of
a high fever and sweating with severe abdominal pain. She also intermittently
complained of dizziness, tinnitus and deafness. The girl became very irritable and
therefore went to bed thinking that this was due to alcohol toxicity. Next morning, she
was found unconscious.
Investigations have revealed the following results: sodium 130 mmol/l, potassium 2.9
mmol/l, urea 9.4 mmol/l, creatinine 115 mol/l, hypoprothrombinaemia and a normal
bleeding time on clotting analysis, blood glucose 2.1 mmol/l, urinalysis test positive and
blood gases showing a compensated metabolic acidosis. She has also presented with
bruising.
What is the diagnosis?
This girl has presented in a compensated metabolic acidosis due to the accumulation of
organic acid secondary to salicylate poisoning. All her symptoms are those found in the acute
phase of the condition, and loss of consciousness is found in the late phase. Other presenting
features and complications include hyperventilation, hyperpyrexia, dehydration, pulmonary
oedema, acute renal failure and irritability.
Physiologically, as there is an increase in initial respiratory alkalosis, bicarbonate is released
in the urine, causing hyponatraemia and hypokalaemia, and water is released in the urine.
This therefore causes a compensatory metabolic acidosis, promoting the accumulation of
lactate pyruvate. A stimulation of fat catabolism leads to ketone and -hydroxybutyrate
production, an increase in protein catabolism and aminoaciduria.
Treatment includes emesis and gastric lavage with activated charcoal. Electrolytes and renal
function need to be corrected, and a forced alkaline diuresis with 0.9% saline, 5% dextrose
and 1.26% bicarbonate solution is required to keep the pH of the urine between 7.5 and 8.5.
The initial hyperventilation in the acute phase causes the respiratory alkalosis and thus the
compensatory metabolic acidosis, which in turn causes the ketonuria. With regard to the
significance of the serum dose levels at 6 hours, the following should be remembered:
3500 mg/l is mild
500750 mg/l is moderate
>750 mg/l is severe.